title: Tacrolimus for steroid- and OKT3-resistant rejection in kidney recipients.
authors.affiliation: Abteilung Nephrologie, Medizinische Hochschule Hannover, Hannover, Germany.
authors.forename: V
authors.initials: V
authors.lastname: Kliem
authors.forename: R
authors.initials: R
authors.lastname: Petersen
authors.forename: G
authors.initials: G
authors.lastname: Ehlerding
authors.forename: D
authors.initials: D
authors.lastname: Schaumann
authors.forename: U
authors.initials: U
authors.lastname: Eisenberger
authors.forename: K M
authors.initials: KM
authors.lastname: Koch
authors.forename: R
authors.initials: R
authors.lastname: Pichlmayr
authors.forename: R
authors.initials: R
authors.lastname: Brunkhorst
mesh_terms: D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D016853:Muromonab-CD3 / Q000627:therapeutic use*; D011239:Prednisolone / Q000627:therapeutic use; D012189:Retrospective Studies; D013256:Steroids / Q000627:therapeutic use*; D016559:Tacrolimus / Q000627:therapeutic use*
chemical_list: D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D013256:Steroids; D016572:Cyclosporine; D011239:Prednisolone; D001379:Azathioprine; D016559:Tacrolimus; D008775:Methylprednisolone